Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 85, Issue 2, Pages 136-138Publisher
WILEY
DOI: 10.1038/clpt.2008.245
Keywords
-
Categories
Ask authors/readers for more resources
The advent of molecularly targeted agents has brought major breakthroughs in oncology. However, because these drugs are expensive and financial resources are limited, attention to their cost-effectiveness is rapidly increasing. It seems that establishment of cost-effectiveness is complex but is determined for the most part by the cost of drug acquisition and the drug's efficacy. This article examines the cost-effectiveness of molecularly targeted drugs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available